TCM

Tekla Capital Management Portfolio holdings

AUM $2.56B
1-Year Est. Return 18.15%
This Quarter Est. Return
1 Year Est. Return
+18.15%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$2.85B
AUM Growth
+$177M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
216
New
Increased
Reduced
Closed

Top Buys

1
+$45.7M
2
+$36.7M
3
+$33.8M
4
NBIX icon
Neurocrine Biosciences
NBIX
+$22.1M
5
DXCM icon
DexCom
DXCM
+$20.7M

Top Sells

1
+$44.1M
2
+$40.6M
3
+$39.8M
4
ABBV icon
AbbVie
ABBV
+$27.3M
5
VRTX icon
Vertex Pharmaceuticals
VRTX
+$22.7M

Sector Composition

1 Healthcare 95.34%
2 Real Estate 2.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
26
$28.3M 0.99%
135,712
+64,471
27
$28.2M 0.99%
294,234
+231,031
28
$28.1M 0.99%
132,344
+35,275
29
$27.6M 0.97%
298,572
+224,396
30
$27.1M 0.95%
109,510
31
$26M 0.91%
705,259
-1,082,080
32
$25.9M 0.91%
248,192
-212,167
33
$25.2M 0.89%
1,256,520
+161,403
34
$24.4M 0.86%
278,330
-47,492
35
$24.2M 0.85%
264,955
-26,200
36
$24M 0.84%
126,779
37
$22.7M 0.8%
174,894
38
$22.7M 0.8%
130,448
+22,911
39
$22.1M 0.78%
175,838
+96,312
40
$19.4M 0.68%
252,971
+92,334
41
$19.2M 0.67%
365,927
-42,546
42
$18.4M 0.65%
83,784
+5,000
43
$18.3M 0.64%
130,937
+66,540
44
$18.1M 0.64%
61,687
45
$17.7M 0.62%
331,789
+81,046
46
$17.4M 0.61%
63,888
-11,319
47
$17.4M 0.61%
34,814
48
$17.2M 0.6%
344,333
49
$16.9M 0.59%
286,013
+261,298
50
$16.4M 0.58%
206,840
1
2
3 4 5